MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
investments
$4,612,484
Proceeds from issuance of
common stock, net of...
$1,084,027
Proceeds from maturity of
investments
$1,000,000
Net cash provided by
(used in) investing...
$2,635,857
Net cash provided by
financing activities
$953,790
Canceled cashflow
$2,976,627
Canceled cashflow
$130,237
Decrease in cash and cash
equivalents
-$18,001,669
Canceled cashflow
$3,589,647
Loss (gain) on equity
investment in affiliated...
-$2,103,688
Prepaid expenses and
other current assets,...
-$852,534
Non-cash stock-based
compensation
$698,744
Amortization of operating
lease right-of-use...
$428,620
Depreciation
$316,844
Loss on sales of
short-term investments
-$284,690
Accrued clinical trial
expenses
$166,651
Purchases of investments
$2,976,627
Taxes paid related to
net share...
-$130,237
Net cash used in
operating activities
-$21,591,316
Canceled cashflow
$4,851,771
Net loss
-$19,682,798
Change in fair value of
common stock warrant...
-$4,137,703
Accounts payable and
accrued expenses,...
-$1,860,676
Operating lease
right-of-use assets and...
-$672,771
Net unrealized gain
on...
$79,077
Amortization of discounts on
investments
$10,062
Back
Back
Cash Flow
INOVIO PHARMACEUTICALS, INC. (INO)
INOVIO PHARMACEUTICALS, INC. (INO)
source: myfinsight.com